Industry Proposes Retiring The Term “Recall,” But FDA Cites Concerns
This article was originally published in The Gray Sheet
Executive Summary
Industry stakeholders say the term "recall" should not be used in reference to medical device field actions because it can lead doctors and patients to assume their products need to be returned or replaced